<SEC-DOCUMENT>0001971857-23-000460.txt : 20230801
<SEC-HEADER>0001971857-23-000460.hdr.sgml : 20230801
<ACCEPTANCE-DATETIME>20230801161204
ACCESSION NUMBER:		0001971857-23-000460
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230801
DATE AS OF CHANGE:		20230801

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEX Inc.
		CENTRAL INDEX KEY:			0001309108
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				010526993
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-32426
		FILM NUMBER:		231131817

	BUSINESS ADDRESS:	
		STREET 1:		97 DARLING AVENUE
		CITY:			SOUTH PORTLAND
		STATE:			ME
		ZIP:			04106
		BUSINESS PHONE:		(207) 773-8171

	MAIL ADDRESS:	
		STREET 1:		97 DARLING AVENUE
		CITY:			SOUTH PORTLAND
		STATE:			ME
		ZIP:			04106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wright Express CORP
		DATE OF NAME CHANGE:	20041118

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carriedo Carlos
		CENTRAL INDEX KEY:			0001904058

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/0 WEX INC.
		STREET 2:		97 DARLING AVENUE
		CITY:			SOUTH PORTLAND
		STATE:			ME
		ZIP:			04106
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001904058</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001309108</issuerCik>
      <issuerName>WEX Inc.</issuerName>
      <secFileNumber>001-32426</secFileNumber>
      <issuerAddress>
        <com:street1>97 DARLING AVENUE</com:street1>
        <com:city>SOUTH PORTLAND</com:city>
        <com:stateOrCountry>ME</com:stateOrCountry>
        <com:zipCode>04106</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(207) 773-8171</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Carriedo Carlos</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>194 Wood Ave. South</com:street1>
          <com:city>Iselin</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08830</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>756</noOfUnitsSold>
      <aggregateMarketValue>144134.03</aggregateMarketValue>
      <noOfUnitsOutstanding>42954003</noOfUnitsOutstanding>
      <approxSaleDate>08/01/2023</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/15/2023</acquiredDate>
      <natureOfAcquisitionTransaction>RSU Vesting</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Carlos Carriedo</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>756</amountOfSecuritiesAcquired>
      <paymentDate>03/23/2023</paymentDate>
      <natureOfPayment>RSU Vesting</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/01/2023</noticeDate>
      <signature>Carlos Carriedo</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
